THMA Pharmacy Growth — 2026 — Carlsbad, USA
Carlsbad, CA . The Health Management Academy's (THMA) Pharmacy Growth Collaborative brings health system pharmacy leaders and select industry executives .
Presentation data updated Jun 10, 2026, 5:33 AM UTC
- Media coverage 10/20
- Speaker quality 15/20
- Pipeline relevance 1/20
- Historical influence 13/20
- Company participation 8/20
Key Takeaways
Key Themes
Key Companies
Key Drugs
Key Markets
Key Opportunities
Key Data to Watch
Topline Results from the Phase 3 PEAK Trial: Tixagevimab/Cilgavimab for Pre-Exposure Prophylaxis of COVID-19
Phase 3 Results of Oral GLP-1 Receptor Agonist for Obesity
A Phase 3 Study of Oral Azacitidine (CC-486) Versus Placebo in Patients with Acute Myeloid Leukemia in First Remission
Updated Results from Phase 1/2 Trial of TCR-T cell therapy in solid tumors
Arcturus Therapeutics: Phase 3 Study of ARCT-810 (mRNA Therapeutic) for Ornithine Transcarbamylase Deficiency
A Randomized Trial of Weekly Semaglutide in Overweight Adults with Type 2 Diabetes